In order to better understand the impact of “Lifestyle Therapy” on diabetes treatment and patient outcomes, a comprehensive longitudinal cohort study is being jointly developed by Kantar Health and Nokia. The novel combination of biometric and longitudinal, real-world data will drive better consumer insights through a holistic, 360-degree view of the diabetes patient. [PR.com]
Support InfoStride News' Credible Journalism: Only credible journalism can guarantee a fair, accountable and transparent society, including democracy and government. It involves a lot of efforts and money. We need your support. Click here to Donate